Strides to acquire 80% stake in Pharmapar Inc. to build its Canadian Operations

Bangalore, India, January 29 2019 - Strides Pharma Science Limited (Strides) today announced that its step down subsidiary Strides Pharma Canada Inc, Canada has today entered into an arrangement to acquire 80% stake in Pharmapar Inc. (Pharmapar), a Canada based specialised generics front end Company. The board of directors of Strides have taken the same on record. 

Founded in 1998, Pharmapar specialises in generic medication to privately insured individuals in Canada. It is a leading pharmaceutical partner to Quebec pharmacies while ensuring adherence to best business practices and stringent compliance. Pharmapar covers over 1,000+ pharmacies with access to 12 banners and 100+ products. 

To read the original press release, click here.